Psychiatry Research
Volume 133, Issue 2 , Pages 129-133 , 28 February 2005

A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia

Received 29 June 2004 ,Revised 31 August 2004 ,Accepted 8 November 2004.

References 

  1. Adams SG, Howe JT. Predicting medication compliance in a psychotic population. Journal of Nervous and Mental Disease. 1993;181:558–560
  2. Ayuso-Gutierrez JL, del Rio Vega JM. Factors influencing relapse in the long-term course of schizophrenia. Schizophrenia Research. 1997;28:199–206
  3. Buchanan RW, Kirkpatrick B, Summerfelt A, Hanlon TE, Levine J, Carpenter WT. Clinical predictors of relapse following neuroleptic withdrawal. Biological Psychiatry. 1992;32:72–78
  4. Diaz E, Levine HB, Sullivan MC, Sernyak MJ, Hawkins KA, Cramer JA, et al. Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. Journal of Psychiatry and Neuroscience. 2001;26:325–329
  5. Duncan JC, Rogers R. Medication compliance in patients with chronic schizophrenia: implications for the community management of mentally disordered offenders. Journal of Forensic Sciences. 1998;43:1133–1137
  6. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clinical Therapeutics. 1999;21:1074–1090(discussion 1073)
  7. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin. 1997;23:637–651
  8. Kemp R, Hayward P, Applewhaite G, Everitt B, David A. Compliance therapy in psychotic patients: randomised controlled trial. British Medical Journal. 1996;312:345–349
  9. Kemp R, Kirov G, Everitt B, Hayward P, David A. Randomised controlled trial of compliance therapy. 18-month follow-up. British Journal of Psychiatry. 1998;172:413–419
  10. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry. 2002;63:892–909
  11. Lieberman JA, Sheitman B, Chakos M, Robinson D, Schooler N, Keith S. The development of treatment resistance in patients with schizophrenia: a clinical and pathophysiologic perspective. Journal of Clinical Psychopharmacology. 1998;18:20S–24S
  12. Liu H, Golin CE, Miller LG, Hays RD, Beck CK, Sanandaji S, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine. 2001;134:968–977
  13. McClellan TA, Cowan G. Use of antipsychotic and antidepressant drugs by chronically ill patients. American Journal of Psychiatry. 1970;126:1771–1773
  14. Nageotte C, Sullivan G, Duan N, Camp PL. Medication compliance among the seriously mentally ill in a public mental health system. Social Psychiatry and Psychiatric Epidemiology. 1997;32:49–56
  15. Norell SE. Accuracy of patient interviews and estimates by clinical staff in determining medication compliance. Social Science and Medicine. Part E: Medical Psychology. 1981;15:57–61
  16. Olfson M, Mechanic D, Hansell S, Boyer CA, Walkup J, Weiden PJ. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatric Services. 2000;51:216–222
  17. Owen RR, Fischer EP, Booth BM, Cuffel BJ. Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatric Services. 1996;47:853–858
  18. Steadman HJ, Mulvey EP, Monahan J, Robbins PC, Appelbaum PS, Grisso T, et al. Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods. Archives General Psychiatry. 1998;55:393–401
  19. Weiden PJ, Olfson M. Cost of relapse in schizophrenia. Schizophrenia Bulletin. 1995;21:419–429
  20. Wyatt RJ. Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin. 1991;17:325–351
  21. Young JL, Zonana HV, Shepler L. Medication noncompliance in schizophrenia: codification and update. Bulletin of the American Academy of Psychiatry and the Law. 1986;14:105–122

PII: S0165-1781(04)00290-2

doi: 10.1016/j.psychres.2004.11.002

Psychiatry Research
Volume 133, Issue 2 , Pages 129-133 , 28 February 2005